In addition, in the brains of sporadic AD patients, an increase in BACE1 levels is correlated with a decrease in a subset of microRNAs (miRNA), especially the miR-29a/b-1 miRNA cluster [218]. This evidence concerns the gene BACE1 and Alzheimer disease.